Participants with MBID with a history of Substance Use Disorder (SUD) who were referred to an outpatient SUD treatment facility Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Between June 2014 and September 2015 twenty-three participants with MBID with a history of SUD who were referred to an outpatient SUD treatment facility were included. Criteria for inclusion in this study were: 1. Dutch as a first language 2. Sufficient oral communication skills (i.e., fluent verbal speakers) 3. A mild to borderline intellectual disability (i.e., full scale IQ between 50 – 85 according to DSM-IV criteria measured by regular intelligence tests, or, when a regular intelligence test were absent the full scale IQ was estimated by the first responsible caregivers) 4. Older than 18 years of age Participants had no restrictions in remaining in other mental health treatment that they were currently receiving (e.g. EMDR or medication management)
Exclusion criteria
Exclusion criteria: 1. Non-Dutch speaking 2. Insufficient oral communication skills 3. A moderate or severe intellectual disability (i.e., full scale IQ below 50) or a normal intelligence according to DSM-IV criteria measured by regular intelligence tests, or, when a regular intelligence test were absent the full scale IQ was estimated by the first responsible caregivers) 4. Younger than 18 years of age 5. Serious psychiatric illnesses with a chance to decompensate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Feasibility of the CBT protocol in terms of acceptability and practicality: 1.1. Therapists complete an acceptability questionnaire after each session. In total therapists completed 18 questionnaires per client 1.2. Both clients and therapists complete a feasibility questionnaire 0 -2 weeks after ending the entire CBT+ protocol 2. Preliminary effectiveness of the treatment (in terms of decreased alcohol, stimulants and cannabis use), measured with the SumID-Q at baseline (0 - 2 weeks before the start of the treatment), post-treatment (0 - 2 weeks after ending the treatment) and at 3-months follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Drop-out rate during the treatment | — |
Countries
Netherlands